ロード中...
Intravenous immunoglobulin in neurological disease: a specialist review
Treatment of neurological disorders with intravenous immunoglobulin (IVIg) is an increasing feature of our practice for an expanding range of indications. For some there is evidence of benefit from randomised controlled trials, whereas for others evidence is anecdotal. The relative rarity of some of...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1737833/ https://ncbi.nlm.nih.gov/pubmed/11909900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.72.4.440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|